A Study of ALT-836 in Combination With Gemcitabine for Locally Advanced or Metastatic Solid Tumors

Clinical trial NCT01325558 · COMPLETED

Trial details

NCT number: NCT01325558
Sponsor: Altor BioScience
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Locally Advanced Malignant Neoplasm Malignant Solid Tumour

Start date: 2011-05-01
Primary completion: 2012-08-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.